Selected research
Industry Research
Sulforaphane Capsule Industry Research Report 2026
Market perspective
The global Sulforaphane Capsule market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sulforaphane Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sulforaphane Capsule is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sulforaphane Capsule is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sulforaphane Capsule include YANGO, Avmacol, Bioherba, Carlyle, Cellavent Healthcare, Coyne, Jarrow Formulas, Matakana and MCS Formulas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sulforaphane Capsule market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sulforaphane Capsule Market by Company
YANGO
Avmacol
Bioherba
Carlyle
Cellavent Healthcare
Coyne
Jarrow Formulas
Matakana
MCS Formulas
Metagenics
SMNutrition
Swanson
Throne
Zein
Sulforaphane Capsule Segment by Type
≤400mg
＞400mg
Sulforaphane Capsule Segment by Application
Offline Sales
Online Sales
Sulforaphane Capsule Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sulforaphane Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sulforaphane Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sulforaphane Capsule.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sulforaphane Capsule manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sulforaphane Capsule by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sulforaphane Capsule in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ≤400mg
- ＞400mg
Applications
- Offline Sales
- Online Sales
Companies covered
- YANGO
- Avmacol
- Bioherba
- Carlyle
- Cellavent Healthcare
- Coyne
- Jarrow Formulas
- Matakana
- MCS Formulas
- Metagenics
- SMNutrition
- Swanson
- Throne
- Zein
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Sulforaphane Capsule Market Size (2021-2032)
- 2.2.2 Global Sulforaphane Capsule Sales (2021-2032)
- 2.2.3 Global Sulforaphane Capsule Market Average Price (2021-2032)
- 2.3 Sulforaphane Capsule by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 ≤400mg
- 2.3.3 ＞400mg
- 2.4 Sulforaphane Capsule by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Offline Sales
- 2.4.3 Online Sales
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sulforaphane Capsule Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Sulforaphane Capsule Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Sulforaphane Capsule Revenue of Manufacturers (2021-2026)
- 3.4 Global Sulforaphane Capsule Average Price by Manufacturers (2021-2026)
- 3.5 Global Sulforaphane Capsule Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Sulforaphane Capsule, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Sulforaphane Capsule, Product Type & Application
- 3.8 Global Manufacturers of Sulforaphane Capsule, Established Date
- 3.9 Global Sulforaphane Capsule Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 YANGO
- 4.1.1 YANGO Company Information
- 4.1.2 YANGO Business Overview
- 4.1.3 YANGO Sulforaphane Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 YANGO Sulforaphane Capsule Product Portfolio
- 4.1.5 YANGO Recent Developments
- 4.2 Avmacol
- 4.2.1 Avmacol Company Information
- 4.2.2 Avmacol Business Overview
- 4.2.3 Avmacol Sulforaphane Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Avmacol Sulforaphane Capsule Product Portfolio
- 4.2.5 Avmacol Recent Developments
- 4.3 Bioherba
- 4.3.1 Bioherba Company Information
- 4.3.2 Bioherba Business Overview
- 4.3.3 Bioherba Sulforaphane Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bioherba Sulforaphane Capsule Product Portfolio
- 4.3.5 Bioherba Recent Developments
- 4.4 Carlyle
- 4.4.1 Carlyle Company Information
- 4.4.2 Carlyle Business Overview
- 4.4.3 Carlyle Sulforaphane Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Carlyle Sulforaphane Capsule Product Portfolio
- 4.4.5 Carlyle Recent Developments
- 4.5 Cellavent Healthcare
- 4.5.1 Cellavent Healthcare Company Information
- 4.5.2 Cellavent Healthcare Business Overview
- 4.5.3 Cellavent Healthcare Sulforaphane Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Cellavent Healthcare Sulforaphane Capsule Product Portfolio
- 4.5.5 Cellavent Healthcare Recent Developments
- 4.6 Coyne
- 4.6.1 Coyne Company Information
- 4.6.2 Coyne Business Overview
- 4.6.3 Coyne Sulforaphane Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Coyne Sulforaphane Capsule Product Portfolio
- 4.6.5 Coyne Recent Developments
- 4.7 Jarrow Formulas
- 4.7.1 Jarrow Formulas Company Information
- 4.7.2 Jarrow Formulas Business Overview
- 4.7.3 Jarrow Formulas Sulforaphane Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Jarrow Formulas Sulforaphane Capsule Product Portfolio
- 4.7.5 Jarrow Formulas Recent Developments
- 4.8 Matakana
- 4.8.1 Matakana Company Information
- 4.8.2 Matakana Business Overview
- 4.8.3 Matakana Sulforaphane Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Matakana Sulforaphane Capsule Product Portfolio
- 4.8.5 Matakana Recent Developments
- 4.9 MCS Formulas
- 4.9.1 MCS Formulas Company Information
- 4.9.2 MCS Formulas Business Overview
- 4.9.3 MCS Formulas Sulforaphane Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 MCS Formulas Sulforaphane Capsule Product Portfolio
- 4.9.5 MCS Formulas Recent Developments
- 4.10 Metagenics
- 4.10.1 Metagenics Company Information
- 4.10.2 Metagenics Business Overview
- 4.10.3 Metagenics Sulforaphane Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Metagenics Sulforaphane Capsule Product Portfolio
- 4.10.5 Metagenics Recent Developments
- 4.11 SMNutrition
- 4.11.1 SMNutrition Company Information
- 4.11.2 SMNutrition Business Overview
- 4.11.3 SMNutrition Sulforaphane Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 SMNutrition Sulforaphane Capsule Product Portfolio
- 4.11.5 SMNutrition Recent Developments
- 4.12 Swanson
- 4.12.1 Swanson Company Information
- 4.12.2 Swanson Business Overview
- 4.12.3 Swanson Sulforaphane Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Swanson Sulforaphane Capsule Product Portfolio
- 4.12.5 Swanson Recent Developments
- 4.13 Throne
- 4.13.1 Throne Company Information
- 4.13.2 Throne Business Overview
- 4.13.3 Throne Sulforaphane Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Throne Sulforaphane Capsule Product Portfolio
- 4.13.5 Throne Recent Developments
- 4.14 Zein
- 4.14.1 Zein Company Information
- 4.14.2 Zein Business Overview
- 4.14.3 Zein Sulforaphane Capsule Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Zein Sulforaphane Capsule Product Portfolio
- 4.14.5 Zein Recent Developments
5 Global Sulforaphane Capsule Market Scenario by Region
- 5.1 Global Sulforaphane Capsule Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sulforaphane Capsule Sales by Region: 2021-2032
- 5.2.1 Global Sulforaphane Capsule Sales by Region: 2021-2026
- 5.2.2 Global Sulforaphane Capsule Sales by Region: 2027-2032
- 5.3 Global Sulforaphane Capsule Revenue by Region: 2021-2032
- 5.3.1 Global Sulforaphane Capsule Revenue by Region: 2021-2026
- 5.3.2 Global Sulforaphane Capsule Revenue by Region: 2027-2032
- 5.4 North America Sulforaphane Capsule Market Facts & Figures by Country
- 5.4.1 North America Sulforaphane Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Sulforaphane Capsule Sales by Country (2021-2032)
- 5.4.3 North America Sulforaphane Capsule Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Sulforaphane Capsule Market Facts & Figures by Country
- 5.5.1 Europe Sulforaphane Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Sulforaphane Capsule Sales by Country (2021-2032)
- 5.5.3 Europe Sulforaphane Capsule Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Sulforaphane Capsule Market Facts & Figures by Country
- 5.6.1 Asia Pacific Sulforaphane Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Sulforaphane Capsule Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Sulforaphane Capsule Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Sulforaphane Capsule Market Facts & Figures by Country
- 5.7.1 South America Sulforaphane Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Sulforaphane Capsule Sales by Country (2021-2032)
- 5.7.3 South America Sulforaphane Capsule Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Sulforaphane Capsule Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Sulforaphane Capsule Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Sulforaphane Capsule Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Sulforaphane Capsule Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Sulforaphane Capsule Sales by Type (2021-2032)
- 6.1.1 Global Sulforaphane Capsule Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Sulforaphane Capsule Sales Market Share by Type (2021-2032)
- 6.2 Global Sulforaphane Capsule Revenue by Type (2021-2032)
- 6.2.1 Global Sulforaphane Capsule Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Sulforaphane Capsule Revenue Market Share by Type (2021-2032)
- 6.3 Global Sulforaphane Capsule Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Sulforaphane Capsule Sales by Application (2021-2032)
- 7.1.1 Global Sulforaphane Capsule Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Sulforaphane Capsule Sales Market Share by Application (2021-2032)
- 7.2 Global Sulforaphane Capsule Revenue by Application (2021-2032)
- 7.2.1 Global Sulforaphane Capsule Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Sulforaphane Capsule Revenue Market Share by Application (2021-2032)
- 7.3 Global Sulforaphane Capsule Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Sulforaphane Capsule Value Chain Analysis
- 8.1.1 Sulforaphane Capsule Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Sulforaphane Capsule Production Mode & Process
- 8.2 Sulforaphane Capsule Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Sulforaphane Capsule Distributors
- 8.2.3 Sulforaphane Capsule Customers
9 Global Sulforaphane Capsule Analyzing Market Dynamics
- 9.1 Sulforaphane Capsule Industry Trends
- 9.2 Sulforaphane Capsule Industry Drivers
- 9.3 Sulforaphane Capsule Industry Opportunities and Challenges
- 9.4 Sulforaphane Capsule Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst